City

Bern 3010 (1)

Nashville (1)

New York (1)

Overall Status

Completed (2)

Not yet recruiting (1)

Sign in for free

Phase

n/a (1)

phase 2/phase 3 (1)

Sponsor

Melissa Toyos (1)

Retina Specialists, PC (1)

University Hospital Inselspital, Berne (1)

Collaborator

Allergan (1)

Bausch & Lomb Incorporated (1)

Intervention

dexamethasone (1)

high-resolution optical coherence tomography (high-res-oct) (1)

ilevro (nepafenac 0.3%) (1)

prolensa (bromfenac 0.07%) (1)

standard spectral domain oct (sd-oct) (1)

Study Documents

Intervention Type

drug (2)

device (1)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

retinal edema

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

High Resolution Optical Coherence Tomography

Not yet recruiting

Retinal Disease
+15 more

High-resolution optical coherence tomography (High-Res-OCT)
Standard spectral domain OCT (SD-OCT)

Bern 3010, Bern, Switzerland

Department of Ophthalmology, Bern University Hospital, Bern, 301

Nov 17, 2021

Cataract, Retinal Edema, Inflammation Trial in Nashville (Prolensa (bromfenac 0.07%), Ilevro (nepafenac 0.3%))

Completed

Cataract
+2 more

Prolensa (bromfenac 0.07%)
Ilevro (nepafenac 0.3%)

Nashville, Tennessee

Toyos Clinic

Oct 14, 2018

Epiretinal Membrane, Cellophane Maculopathy, Macular Edema Trial in New York (Dexamethasone, dexamethasone)

Completed

Epiretinal Membrane
+3 more

New York, New York

Retina Specialists PC

May 12, 2015